Physician profile
Michael Mcdonald
NPI 1457892879
$33,097.73
in general payments reported to CMS, 2019-2025
18 companies · $1,078 in 2025
The $1,078 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,970 · 2020: $558 · 2021: $12K · 2022: $6,457 · 2023: $1,942 · 2024: $936 · 2025: $1,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051 · Travel and Lodging: $1,731 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,051.09 |
| Travel and Lodging | $1,731.28 |
| Education | $173.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $20,905.05 | 2019-2022 | |
| Stryker Corporation | $4,862.74 | 2019-2025 | T2 Alpha, Hoffmann, Pelvis II |
| Zimmer Biomet Holdings, INC. | $2,484.47 | 2019-2025 | A.L.P.S., Synovasure Alpha Defensin, Biocue |
| Medical Device Business Services, INC. | $2,408.51 | 2019-2023 | |
| Globus Medical, INC. | $928.35 | 2024-2025 | Anthem, Distal Femur Plate System |
| Avanos Medical | $422.83 | 2019-2021 | |
| Smith+Nephew, INC. | $287.16 | 2022 | |
| Depuy Synthes Sales INC. | $210.27 | 2019-2023 | Na, Trumatch, Va-Lcp |
| Innovation Technologies INC | $145.41 | 2022 | |
| Si-Bone, INC. | $125.00 | 2020 | |
| Davol INC. | $119.47 | 2022 | |
| Pacira Therapeutics, INC. | $102.50 | 2019 | |
| Biocomposites INC | $25.12 | 2024 | |
| Ebi, LLC | $16.80 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System |
| Ferring Pharmaceuticals INC. | $14.94 | 2024 | Euflexxa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $13.95 | 2022 | |
| Zimvie INC. | $12.80 | 2023 | |
| Abbvie INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.